Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of geriatric oncology"
DOI: 10.1016/j.jgo.2017.07.010
Abstract: OBJECTIVES Aflibercept (ziv-aflibercept) significantly improves progression-free (PFS) and overall survival (OS) when added to 5-fluorouracil, leucovorin and irinotecan (FOLFIRI), compared with FOLFIRI alone, in patients with metastatic colorectal cancer previously treated with oxaliplatin-based therapy. This… read more here.
Keywords: arm; 65years old; age; versus ... See more keywords